Psychomotor performance under neuroleptic treatment in schizophrenia: A comparative study of haloperidol and risperidone;Psychophysische Leistungsfähigkeit unter neuroleptischer Behandlung bei Schizophrenen: Eine Vergleichsuntersuchung von Haloperidol und Risperidone

Zeitschrift fur Neuropsychologie

Volumn 12, Issue 1, 2001, Pages 49-53

  Soyka, Michael ^a   Dittert, Sebastian ^a   Schäfer, Martin ^a   Gartenmaier, Andreas ^a   Laux, Gerd ^b   Winter, Catja ^a   Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b District Hospital Gabersee   (Germany)

Author keywords

Driving ability; Haloperidol; Psychomotor performance; Risperidone; Schizophrenia

Indexed keywords

EID: 0002255611     PISSN: 1016264X     EISSN: None     Source Type: Journal    
DOI: 10.1024//1016-264X.12.1.49     Document Type: Article

References (20)

1. Bartl, G., Lager, F. &Domesle, L. (1996). Test performance in people under minor influence of alcohol. Blutalkohol, 3, 1-16.
2. Bilder, R.M., Turkel, E., Lipschutz-Broch, L. &Liebermann, J.A. (1992). Antipsychotic medication effects on neuropsychological function. Psychopharmacology Bulletin, 28, 353-366.
3. Bukasa, B., Wenninger, U. &Brandstätter, Ch. (1990). Validierung verkehrspsychologischer Testverfahren. Kleine Fachbuchreihe des Kuratoriums für Verkehrssicherheit. Wien: Literas.
4. Cassens, G., Inglis, A.K., Appelbaum, P.S. &Gutheil, T.G. (1990). Neuroleptics: Effects of neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16, 477-499.
5. Cleghorn, J.M., Kaplan, R.D., Szechtman, B., Szechtman, H. &Brown, G.M. (1990). Neuroleptic drug effects on cognitive function in schizophrenia. Schizophrenia Research, 3, 211-219.
6. Dittert, S., Naber, D. &Soyka, M. (1999). Methadone substitution and ability to drive. Results of an experimental study. Der Nervenarzt, 70, 457-462.
7. Gallhofer, B., Bauer, U., Lis, S., Krieger, S. &Gruppe, H. (1996). Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. European Neuropsychopharmacology, 6, S2-S13.
8. Grabe, H.J., Wolf, T., Grätz, S. &Laux, G. (1998). The influence of polypharmacological antidepressive treatment on central nervous information processing of depressed patients: Implications for fitness to drive. Neuropsychobiology, 37, 200-204.
9. Green, M.F., Marschall, B.D., Wirshing, W.C., Ames, D., Marder, S.R., McGurk, S., Kern, R.S. &Mintz, J. (1997). Does risperidone improve verbal working memory in treatment-resistant schizophrenia?. American Journal of Psychiatry, 154, 799-804.
10. Hindmarch, I. (1982). Critical Flicker Fusion Frequency (CFFT). The effects of psychotropic compounds. Pharmacopsychiatria, 15(suppl), 44-48.
11. Kern, R.S., Green, M.F., Marshall, B.D., Jr., Wirshing, W.C., Wirshing, A., McGurk, S., Marder, S.R. &Mintz, J. (1998). Risperidone vs. haloperidol on reaction time, manual dexterity and motor learning in treatment-resistant schizophrenia patients. Biological Psychiatry, 44, 726-732.
12. King, D.J. (1990). The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799-811.
13. Meltzer, H.J., Thompson, P.A., Myung, A.L. &Ranjan, R. (1996). Neuropsychologic deficits in schizophrenia-relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology, 14, 27-33.
14. Overall, J.E. &Gorham, D.R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
15. Owens, D.G.C. (1994). Extrapyramidal side effects and tolerability of risperidone: A review. Journal of Clinical Psychiatry, 55(Suppl.5), 29-35.
16. Pickar, D. (1995). Prospects for pharmacotherapy of schizophrenia. Lancet, 345, 557-562.
17. Rossi, A., Mancini, F., Stratta, P., Mattei, P., Gismondi, R., Pozzi, F. &Casacchia, M. (1997). Risperidone, negative symptoms and cognitive deficit in schizophrenia: An open study. Acta Psychiatrica Scandinavica, 95, 40-43.
18. Soyka, M., Dittert, S., Gartenmaier, A. &Schäfer, M. (1998). Fahrtauglichkeit unter Therapie mit Antidepressiva (Driving ability in patients with antidepressants). Versicherungsmedizin, 50, 332-340.
19. Soyka, M., Preuss, U., Aichmüller, C. &Möller, H.J. (1998). Effects of acamprosate on psychomotor performance and driving ability in abstinent alcoholics. Pharmacopsychiatry, 31, 1-4.
20. Stip, E. &Lussier, I. (1996). The Effect of risperidone on cognition in patients with schizophrenia. Canadian Journal of Psychiatry, 41(suppl. 2), 35-40.